Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ventyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. […]

The following statement is being issued by Kroll Settlement Administration regarding In re PVC Pipe Antitrust Litigation. A settlement has been reached in a class action lawsuit called In re PVC Pipe Antitrust Litigation, No. 1:24-cv-07639 (the “Lawsuit”), which is pending in the United States District Court for the Northern District of Illinois (the “Court”)

Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. (“Nutanix” or the “Company”) (NASDAQ: NTNX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nutanix and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click

Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ADC Therapeutics and certain of its officers and/or directors have engaged in securities fraud or other unlawful

Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. (“Aerovironment” or the “Company”) (NASDAQ: AVAV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Aerovironment and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click

Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. (“Apogee” or the “Company”) (NASDAQ: APOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Apogee and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. (“SNDL” or the “Company”) (NASDAQ: SNDL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SNDL and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click

Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. (“LENZ” or the “Company”) (NASDAQ: LENZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether LENZ and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. (“First Solar” or the “Company”) (NASDAQ: FSLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether First Solar and certain of its officers and/or directors have engaged in securities fraud or other unlawful

Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation (“Xoma” or the “Company”) (NASDAQ: XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xoma and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.